SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Michael Greene who wrote (877)5/7/1998 10:34:00 PM
From: John Bloxom  Read Replies (2) | Respond to of 2135
 
Thanks for your post, Michael. Bloomberg is about the only wire to which I do not have access. I would appreciate your posting relevant portions of the article here if you could. The production issue is, as you know, a very important one. I have heard conflicting stories regarding the extent to which the company has succeeded in overcoming the problems and therefore would be grateful for any light you might be able to bring to the issue.

Regards,

John



To: Michael Greene who wrote (877)5/8/1998 1:16:00 AM
From: muddphudd  Respond to of 2135
 
"I was also pleased to see in the Bloomberg article that ENMD now has a process capable of making enough of the drugs to support human testing."

Do you have a link to the Bloomberg article? I would very much like to read it. Did they mention what method they are using to mass produce the drugs?

Thanks.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News